M 17

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 531299

CAS#: 55566-03-5

Description: M 17 is a bioactive chemical.


Chemical Structure

img
M 17
CAS# 55566-03-5

Theoretical Analysis

MedKoo Cat#: 531299
Name: M 17
CAS#: 55566-03-5
Chemical Formula: C22H28Cl2N2O2
Exact Mass: 422.1528
Molecular Weight: 423.378
Elemental Analysis: C, 62.41; H, 6.67; Cl, 16.75; N, 6.62; O, 7.56

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: M 17

IUPAC/Chemical Name: 1-Piperidineacetamide, N-(2-(p-chlorophenoxy)ethyl)-N-(o-tolyl)-, hydrochloride

InChi Key: NHRJXDCEJAJBJO-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H27ClN2O2.ClH/c1-18-7-3-4-8-21(18)25(22(26)17-24-13-5-2-6-14-24)15-16-27-20-11-9-19(23)10-12-20;/h3-4,7-12H,2,5-6,13-17H2,1H3;1H

SMILES Code: O=C(N(CCOC1=CC=C(Cl)C=C1)C2=CC=CC=C2C)CN3CCCCC3.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 423.378 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Grgic O, Chung K, Shevroja E, Trajanoska K, Uitterlinden AG, Wolvius EB, Rivadeneira F, Medina-Gomez C. Fractures in school age children in relation to sex and ethnic background: The Generation R Study. Bone. 2019 Jan 21. pii: S8756-3282(19)30020-1. doi: 10.1016/j.bone.2019.01.019. [Epub ahead of print] PubMed PMID: 30677542.

2: Moser O, Eckstein ML, Mueller A, Birnbaumer P, Aberer F, Koehler G, Sourij C, Kojzar H, Holler P, Simi H, Pferschy P, Dietz P, Bracken RM, Hofmann P, Sourij H. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial. Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13909. [Epub ahead of print] PubMed PMID: 30677187.

3: Dobbin N, Highton J, Moss SL, Twist C. Factors Affecting the Anthropometric and Physical Characteristics of Elite Academy Rugby League Players: A Multi-Club Study. Int J Sports Physiol Perform. 2019 Jan 24:1-32. doi: 10.1123/ijspp.2018-0631. [Epub ahead of print] PubMed PMID: 30676811.

4: Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 Jan 24:e1-e3. doi: 10.2105/AJPH.2018.304856. [Epub ahead of print] PubMed PMID: 30676789.

5: Mager DR, Hager A, Siminoski K, Yap JK, Gilmour SM. Healthy Body Weights With Corticosteroid-Free Immunosuppression Is The Best Predictor of Cardiovascular Health In Children After Liver Transplantation. J Pediatr Gastroenterol Nutr. 2019 Jan 21. doi: 10.1097/MPG.0000000000002271. [Epub ahead of print] PubMed PMID: 30676521.

6: Bendib I, de Chaisemartin L, Granger V, Schlemmer F, Maitre B, Hüe S, Surenaud M, Beldi-Ferchiou A, Carteaux G, Razazi K, Chollet-Martin S, Mekontso Dessap A, de Prost N. Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome. Anesthesiology. 2019 Jan 22. doi: 10.1097/ALN.0000000000002619. [Epub ahead of print] PubMed PMID: 30676417.

7: Young D, Mourot L, Beato M, Coratella G. Match-Play Demands of Elite U17 Hurlers During Competitive Matches. J Strength Cond Res. 2019 Jan 22. doi: 10.1519/JSC.0000000000002945. [Epub ahead of print] PubMed PMID: 30676392.

8: Nabti LZ, Sahli F, Radji N, Mezaghcha W, Semara L, Aberkane S, Lounnas M, Solassol J, Didelot MN, Jean-Pierre H, Dumont Y, Godreuil S. High Prevalence of Multidrug-Resistant Escherichia coli in Urine Samples from Inpatients and Outpatients at a Tertiary Care Hospital in Sétif, Algeria. Microb Drug Resist. 2019 Jan 24. doi: 10.1089/mdr.2018.0314. [Epub ahead of print] PubMed PMID: 30676258.

9: Gurchiek RD, Don HSRA, Watagoda LCRP, McGinnis RS, van Werkhoven H, Needle AR, McBride JM, Arnholt AT. Sprint Assessment Using Machine Learning and a Wearable Accelerometer. J Appl Biomech. 2019 Jan 24:1-16. doi: 10.1123/jab.2018-0107. [Epub ahead of print] PubMed PMID: 30676153.

10: Johnston S, Martin M, Di Leo A, Im SA, Awada A, Forrester T, Frenzel M, Hardebeck MC, Cox J, Barriga S, Toi M, Iwata H, Goetz MP. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer. NPJ Breast Cancer. 2019 Jan 17;5:5. doi: 10.1038/s41523-018-0097-z. eCollection 2019. PubMed PMID: 30675515; PubMed Central PMCID: PMC6336880.

11: Nagasawa M, Kageyama S, Yoshida T, Okinaka Y, Kubota S, Wada A, Kobayashi K, Tomita K, Murai R, Tsuru T, Johnin K, Narita M, Kawauchi A. Changes in renal function following nedaplatin-containing chemotherapy in patients with urothelial carcinoma unfit for cisplatin. Oncol Lett. 2019 Feb;17(2):2551-2556. doi: 10.3892/ol.2018.9859. Epub 2018 Dec 20. PubMed PMID: 30675317; PubMed Central PMCID: PMC6341835.

12: Sun G, Zhang C, Song H, Guo J, Li M, Cao Y. WZY-321, a novel evodiamine analog, inhibits glioma cell growth in an autophagy-associated manner. Oncol Lett. 2019 Feb;17(2):2465-2472. doi: 10.3892/ol.2018.9847. Epub 2018 Dec 18. PubMed PMID: 30675312; PubMed Central PMCID: PMC6341813.

13: Fu C, Wang L, Tian G, Zhang C, Zhao Y, Xu H, Su M, Wang Y. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells. Oncol Lett. 2019 Feb;17(2):1798-1806. doi: 10.3892/ol.2018.9796. Epub 2018 Dec 5. PubMed PMID: 30675240; PubMed Central PMCID: PMC6341778.

14: Carlberg M, Hedendahl L, Koppel T, Hardell L. High ambient radiofrequency radiation in Stockholm city, Sweden. Oncol Lett. 2019 Feb;17(2):1777-1783. doi: 10.3892/ol.2018.9789. Epub 2018 Dec 3. PubMed PMID: 30675237; PubMed Central PMCID: PMC6341832.

15: Hu L, Sun F, Sun Z, Ni X, Wang J, Wang J, Zhou M, Feng Y, Kong Z, Hua Q, Yu J. Apatinib enhances the radiosensitivity of the esophageal cancer cell line KYSE-150 by inducing apoptosis and cell cycle redistribution. Oncol Lett. 2019 Feb;17(2):1609-1616. doi: 10.3892/ol.2018.9803. Epub 2018 Dec 6. PubMed PMID: 30675220; PubMed Central PMCID: PMC6341789.

16: Sinha R, Bana R, Sanjay M. Comparison of Robotic and Laparoscopic Hysterectomy for the Large Uterus. JSLS. 2019 Jan-Mar;23(1). pii: e2018.00068. doi: 10.4293/JSLS.2018.00068. PubMed PMID: 30675091; PubMed Central PMCID: PMC6328360.

17: Gerlicher AMV, Tüscher O, Kalisch R. Author Correction: Dopamine-dependent prefrontal reactivations explain long-term benefit of fear extinction. Nat Commun. 2019 Jan 23;10(1):471. doi: 10.1038/s41467-019-08399-4. PubMed PMID: 30674882.

18: Adams DR, Menezes S, Jauregui R, Valivullah ZM, Power B, Abraham M, Jeffrey BG, Garced A, Alur RP, Cunningham D, Wiggs E, Merideth MA, Chiang PW, Bernstein S, Ito S, Wakamatsu K, Jack RM, Introne WJ, Gahl WA, Brooks BP. One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B. JCI Insight. 2019 Jan 24;4(2). pii: 124387. doi: 10.1172/jci.insight.124387. [Epub ahead of print] PubMed PMID: 30674731.

19: Taylor M, Jefferies J, Byrne B, Lima J, Ambale-Venkatesh B, Ostovaneh MR, Makkar R, Goldstein B, Smith RR, Fudge J, Malliaras K, Fedor B, Rudy J, Pogoda JM, Marbán L, Ascheim DD, Marbán E, Victor RG. Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial. Neurology. 2019 Jan 23. pii: 10.1212/WNL.0000000000006950. doi: 10.1212/WNL.0000000000006950. [Epub ahead of print] PubMed PMID: 30674601.

20: Wollenweber FA, Opherk C, Zedde M, Catak C, Malik R, Duering M, Konieczny MJ, Pascarella R, Samões R, Correia M, Martí-Fàbregas J, Linn J, Dichgans M. Prognostic relevance of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology. 2019 Jan 23. pii: 10.1212/WNL.0000000000006956. doi: 10.1212/WNL.0000000000006956. [Epub ahead of print] PubMed PMID: 30674596.